Abstract
Comprehensive studies and numerous clinical reports have shown that griseofulvin orally in a dose of 1 gm. daily is an effective treatment for superficial fungous infections of the skin, hair and nails. The drug is not effective against yeast infections (moniliasis), bacterial infections or most of the deep fungous infections.
Duration of treatment varies with the site of infection, glabrous skin, crotch and scalp responding within four to five weeks. Infections of palms, soles and nails require a considerably longer time, palms healing more quickly than soles and fingernails more quickly than toenails, which may require up to a year of continuous treatment.
Auxiliary measures such as clipping hair, removing infected nail tissue and topical fungicides shorten the duration of treatment.
No serious side effects have been reported. Minor discomforts such as headaches and mild rashes occur in some cases.
Observations of a series of 49 patients with superficial fungous infections, especially hand, foot and nail infections due to Trichophyton rubrum, confirmed these reports taken from the literature. Attempts to use a reduced dosage schedule did not prove satisfactory.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BERRY C. Z., SHAPIRO S. I., DAHLEN R. F. Recurrence of Trichophyton rubrum infection during treatment with griseofulvin. Report of a case. Arch Dermatol. 1960 Jun;81:982–982. doi: 10.1001/archderm.1960.03730060098024. [DOI] [PubMed] [Google Scholar]
- BLANK H., ROTH F. J., Jr The treatment of dermatomycoses with orally administered griseofulvin. AMA Arch Derm. 1959 Mar;79(3):259–266. doi: 10.1001/archderm.1959.01560150001001. [DOI] [PubMed] [Google Scholar]
- BLANK H., SMITH J. G., Jr, ROTH F. J., Jr, ZAIAS N. Griseofulvin for the systemic treatment of dermatomycoses. J Am Med Assoc. 1959 Dec 19;171:2168–2173. doi: 10.1001/jama.1959.03010340012003. [DOI] [PubMed] [Google Scholar]
- BURGOON C. F., Jr, GRAHAM J. H., KEIPER R. J., URBACH F., BURGOON J. S., HELWIG E. B. Histopathologic evaluation of griseofulvin in Microsporum audouini infections. Arch Dermatol. 1960 May;81:724–732. doi: 10.1001/archderm.1960.03730050080014. [DOI] [PubMed] [Google Scholar]
- COHEN A., GOLDMAN J., DANIELS R., KANENSON W. Treatment of shoulder-hand syndrome with griseofulvin. J Am Med Assoc. 1960 Jun 4;173:542–543. doi: 10.1001/jama.1960.73020230041009. [DOI] [PubMed] [Google Scholar]
- DESAI S. C. Effect of griseofulvin on Trichophyton rubrum and Trichophyton violaceum infections. Clinicomycological correlation of the mode of action in tissue. Arch Dermatol. 1960 May;81:849–858. doi: 10.1001/archderm.1960.03730050205037. [DOI] [PubMed] [Google Scholar]
- GOLDFARB N. J., SULZBERGER M. B. Experiences in one hundred thirty-seven patients treated with oral griseofulvin. Special reference to clinical recurrences. the healthy carrier state, and their management. Arch Dermatol. 1960 May;81:859–862. doi: 10.1001/archderm.1960.03730050215038. [DOI] [PubMed] [Google Scholar]
- LAZAR P., RATTNER H. Griseofulvin therapy for superficial fungus infections. Effect upon concurrent diseases. Arch Dermatol. 1960 May;81:863–865. doi: 10.1001/archderm.1960.03730050219039. [DOI] [PubMed] [Google Scholar]
- MACLEOD J., NELSON W. O. Griseofulvin and human spermatogenesis. Arch Dermatol. 1960 May;81:758–759. [PubMed] [Google Scholar]
- PAGET G. E., WALPOLE A. L. The experimental toxicology of griseofulvin. Arch Dermatol. 1960 May;81:750–757. doi: 10.1001/archderm.1960.03730050106018. [DOI] [PubMed] [Google Scholar]
- ROSENTHAL S. A., WISE R. S. Studies concerning the development of resistance to griseofulvin by dermatophytes. Arch Dermatol. 1960 May;81:684–689. doi: 10.1001/archderm.1960.03730050040007. [DOI] [PubMed] [Google Scholar]
- ROTH F. J., Jr, BLANK H. The bioassay of griseofulvin in human stratum corneum. Arch Dermatol. 1960 May;81:662–666. doi: 10.1001/archderm.1960.03730050018004. [DOI] [PubMed] [Google Scholar]